Hence, we believe the findings reported in this study may improve our understanding of the CYP3A4 protein binding landscape, which in turn could pave the way for an understanding of the use of ivermectin as an alternative treatment for COVID-19 by individuals with diabetes and/or hypertension. Here, CYP3A4 is linked to COVID-19.